Skip to main content
Log in

A Putative Mitotic Checkpoint Dependent on mTOR Function Controls Cell Proliferation and Survival in Ovarian Granulosa Cells

  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

The conserved target of rapamycin (TOR) proteins are involved in sensing nutrient levels and/or stress and the resultant control of cell growth, size, and survival. The authors assess mammalian TOR (mTOR) kinase expression in the mouse ovary and also the expression of its cofactors, Raptor, Rictor, and LST8. In granulosa cells, mTOR demonstrates high cytoplasmic/perinuclear expression. The kinase-active serine 2448—phosphorylated form of mTOR (P-mTOR) is present at very high levels during the M-phase. P-mTOR was enriched on or near the mitotic spindle and also near the contractile ring during cytokinesis. Rapamycin inhibition of mTOR resulted in both reduced granulosa cell proliferation and reduced follicle growth in vitro, each in a dose-dependent fashion. Follicles cultured in rapamycin did not undergo atresia. mTOR inhibition results in a reduction in granulosa cell proliferation, supporting a model in which stress and nutritional cues may directly influence ovarian follicle growth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Quirk SM, Cowan RG, Harman RM, Hu CL, Porter DA Ovarian follicular growth and atresia: the relationship between cell proliferation and survival. J Anim Sci. 2004; 82(E-suppl).

  2. Pangas SA, Matzuk MM Genetic models for transforming growth factor beta superfamily signaling in ovarian follicle development. Mol Cell Endocrinol. 2004;225:83–91.

    Article  CAS  Google Scholar 

  3. Wullschleger S., Loewith R., Hall MN Tor signaling in growth and metabolism. Cell. 2006;124:471–484.

    Article  CAS  Google Scholar 

  4. Eskelinen EL, Prescott AR, Cooper J., et al. Inhibition of autophagy in mitotic animal cells. Traffic. 2002;3:878–893.

    Article  CAS  Google Scholar 

  5. Wiederrecht GJ, Sabers CJ, Brunn GJ, Martin MM, Dumont FJ, Abraham RT Mechanism of action of rapamycin: new insights into the regulation of g1-phase progression in eukaryotic cells. Prog Cell Cycle Res. 1995;1:53–71.

    Article  CAS  Google Scholar 

  6. Kim DH, Sarbassov DD, Ali SM, et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell. 2002;110:163–175.

    Article  CAS  Google Scholar 

  7. Kim DH, Sabatini DM Raptor and mTOR: subunits of a nutrient-sensitive complex. Curr Topics Microbiol Immunol. 2004;279:259–270.

    CAS  Google Scholar 

  8. Jacinto E., Loewith R., Schmidt A., et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol. 2004;6:1122–1128.

    Article  CAS  Google Scholar 

  9. Wullschleger S., Loewith R., Oppliger W., Hall MNN. Molecular organization of target of rapamycin complex 2. J Biol Chem. 2005;280:30697–30704.

    Article  CAS  Google Scholar 

  10. Sarbassov DD, Ali SM, Sengupta S., et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and akt/pkb. Mol Cell. 2006;22:159–168.

    Article  CAS  Google Scholar 

  11. Heitman J., Movva NR, Hall MN Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science. 1991;253:905–909.

    Article  CAS  Google Scholar 

  12. Choe G., Horvath S., Cloughesy TF, et al. Analysis of the phosphatidylinositol 3′-kinase signaling pathway in glioblastoma patients in vivo. Cancer Res. 2003;63:2742–2746.

    CAS  PubMed  Google Scholar 

  13. Zhou X., Tan M., Stone Hawthorne V., et al. Activation of the akt/mammalian target of rapamycin/4e-bp1 pathway by erbb2 overexpression predicts tumor progression in breast cancers. Clin Cancer Res. 2004;10:6779–6788.

    Article  CAS  Google Scholar 

  14. Altomare DA, Wang HQ, Skele KL, et al. Akt and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene. 2004;23:5853–5857.

    Article  CAS  Google Scholar 

  15. Chiang GG, Abraham RT Phosphorylation of mammalian target of rapamycin (mTOR) at ser-2448 is mediated by p70s6 kinase. J Biol Chem. 2005;280:25485–25490.

    Article  CAS  Google Scholar 

  16. Nav BT, Ouwens M., Withers DJ, Alessi DR, Shepherd PR Mammalian target of rapamycin is a direct target for protein kinase b: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem J. 1999;344(pt 2):427–431.

    Article  Google Scholar 

  17. Sekuli A., Hudson CC, Homme JL, et al. A direct linkage between the phosphoinositide 3-kinase-akt signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res. 2000;60:3504–3513.

    Google Scholar 

  18. Alam H., Maizels ET, Park Y., et al. Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/akt/ras homolog enriched in brain (rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation. J Biol Chem. 2004;279:19431–19440.

    Article  CAS  Google Scholar 

  19. Arvisais EWW, Romanelli A., Hou X., Davis JSS. Aktindependent phosphorylation of TSC2 and activation of mTOR and ribosomal protein s6 kinase signaling by prostaglandin f2α. J Biol Chem. 2006;281:26904–26913.

    Article  CAS  Google Scholar 

  20. Zhang X., Shu L., Hosoi H., Murti GK, Houghton PJ Predominant nuclear localization of mammalian target of rapamycin in normal and malignant cells in culture. J Biol Chem. 2002;277:28127–28134.

    Article  CAS  Google Scholar 

  21. Drenan RM, Liu X., Bertram PG, Zheng XF Fkbp12-rapamycin associated protein or mammalian target of rapamycin (FRAP/mTOR) localization in the endoplasmic reticulum and the Golgi apparatus. J Biol Chem. 2004; 279:772–778.

    Article  CAS  Google Scholar 

  22. Berven LA, Willard FS, Crouch MF Role of the p70s6k pathway in regulating the actin cytoskeleton and cell migration. Exp Cell Res. 2004;296:183–195.

    Article  CAS  Google Scholar 

  23. Straszewski-Chavez SL, Abrahams VM, Funai EF, Mor G. X-linked inhibitor of apoptosis (XIAP) confers human trophoblast cell resistance to Fas-mediated apoptosis. Mol Hum Reprod. 2004;10:33–41.

    Article  CAS  Google Scholar 

  24. Neale D., Demasio K., Illuzi J., Chaiworapongsa T., Romero R., Mor G. Maternal serum of women with pre-eclampsia reduces trophoblast cell viability: evidence for an increased sensitivity to Fas-mediated apoptosis. J Matern Fetal Neonatal Med. 2003;13:39–44.

    Article  CAS  Google Scholar 

  25. Cortvrindt R., Smitz J., Van Steirteghem AC Assessment of the need for follicle stimulating hormone in early preantral mouse follicle culture in vitro. Hum Reprod. 1997;12:759–768.

    Article  CAS  Google Scholar 

  26. Tapia C., Kutzner H., Mentzel T., Savic S., Baumhoer D., Glatz K. Two mitosis-specific antibodies, 508 mpm-2 and phosphohistone h3 (ser28), allow rapid and precise determination of mitotic activity. Am J Surg Pathol. 2006;30:83–89.

    Article  Google Scholar 

  27. Dormond O., Madsen JC, Briscoe DM The effects of mTOR-Akt interactions on anti-apoptotic signaling in vascular endothelial cells. J Biol Chem. 2007;282:23679–23686.

    Article  CAS  Google Scholar 

  28. Migita K., Eguchi K., Ichinose Y., et al. Effects of rapamycin on apoptosis of rheumatoid synovial cells. Clin Exp Immunol. 1997;108:199–203.

    Article  CAS  Google Scholar 

  29. Choi JH, Adames NR, Chan TF, Zeng C., Cooper JA, Zheng SXF. Tor signaling regulates microtubule structure and function. Curr Biol. 2000;10:861–864.

    Article  CAS  Google Scholar 

  30. Hidayat S., Yoshino K., Tokunaga C., Hara K., Matsuo M., Yonezawa K. Inhibition of amino acid-mTOR signaling by a leucine derivative induces g1 arrest in Jurkat cells. Biochem Biophys Res Commun. 2003;301:417–423.

    Article  CAS  Google Scholar 

  31. Gao N., Flynn DC, Zhang Z., et al. G1 cell cycle progression and the expression of g1 cyclins are regulated by PI3K/AKT/ mTOR/P70S6K1 signaling in human ovarian cancer cells. Am J Physiol Cell Physiol. 2004;287:C281–C291.

    Article  CAS  Google Scholar 

  32. Song J., Salek-Ardakani S., So T., Croft M. The kinases aurora b and mTOR regulate the g1s cell cycle progression of T lymphocytes. Nat Immunol. 2006;8:64–73.

    Article  Google Scholar 

  33. van Opstal A., Boonstra J. Inhibitors of phosphatidylinositol 3-kinase activity prevent cell cycle progression and induce apoptosis at the M/G1 transition in CHO cells. Cell Mol Life Sci. 2006;63:220–228.

    Article  Google Scholar 

  34. Rubio-Viqueira B., Hidalgo M. Targeting mTOR for cancer treastment. Curr Opin Investig Drugs. 2006;7:501–512.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joshua Johnson PhD.

Additional information

We would like to thank Dr John S. Davis for commentary on the article prior to submission. Dr Vikki M. Abrahams provided invaluable assistance with cell viability assessment. Jimmy Hom and Brett Carisio are also thanked for enthusiastic, helpful technical assistance.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yaba, A., Bianchi, V., Borini, A. et al. A Putative Mitotic Checkpoint Dependent on mTOR Function Controls Cell Proliferation and Survival in Ovarian Granulosa Cells. Reprod. Sci. 15, 128–138 (2008). https://doi.org/10.1177/1933719107312037

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719107312037

Key words

Navigation